Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blistering disorders in childhood.

L F Eichenfield1, P J Honig

  • 1Department of Pediatrics and Medicine (Dermatology), University of California, San Diego.

Pediatric Clinics of North America
|August 1, 1991
PubMed
Summary

This review covers childhood blistering disorders, including rare and common conditions like epidermolysis bullosa and erythema multiforme. It provides updated information for physicians on diagnosing and managing these pediatric skin conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Topical therapy of atopic dermatitis with a focus on pimecrolimus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.

The Journal of dermatological treatment·2020
Same author

A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.

The British journal of dermatology·2020
Same author

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.

The British journal of dermatology·2020

Area of Science:

  • Pediatric Dermatology
  • Vesiculobullous Disorders

Background:

  • Childhood presents diverse blistering conditions, from mild to severe.
  • Accurate diagnosis is crucial for appropriate management.

Purpose of the Study:

  • To review key childhood blistering disorders.
  • To highlight new information for practicing physicians.
  • To cover a range of conditions from infections to genetic disorders.

Main Methods:

  • Literature review of selected blistering disorders in children.
  • Focus on conditions relevant to clinical practice.

Main Results:

  • Discusses childhood zoster, fetal varicella syndrome, urticaria pigmentosa, scabies, bullous bug bites, lichen sclerosus et atrophicus, epidermolysis bullosa, and erythema multiforme.
  • Emphasizes practical, updated information for physicians.

Conclusions:

  • Physicians need current knowledge of pediatric blistering disorders.
  • Early recognition and management are vital for patient outcomes.

Related Experiment Videos